Sergamumo Ir Pirmalaikio Mirtingumo Nuo Kraujotakos Sistemos Ligų Mažinimo Krypties Aprašas

Objectives

The plan seeks to reduce cardiovascular disease incidence, disability and premature mortality, particularly among people aged 0–64 in Lithuanian municipalities with cardiovascular mortality at least 20% above the national average. It aims to enable longer, healthier, more independent and economically active lives by improving prevention, early diagnosis, timely treatment, rehabilitation and equitable access to high-quality services.[1][2]Cardiovascular diseases are treated as a major public-health priority, having accounted for 56.6% of deaths in Lithuania in 2012.[3]

• Reduce modifiable risk factors, particularly tobacco use, arterial hypertension, dyslipidaemia, unhealthy diet, insufficient physical activity, overweight, obesity, alcohol-related harm and work-related stress.[4][5][6]
• Promote healthy nutrition by reducing saturated fat, salt and sugar and increasing fibre, fruit and vegetables, alongside wider physical-activity promotion and practical healthy-lifestyle skills.[7][8]
• Strengthen primary prevention for people without symptoms and secondary prevention to delay disease progression, avoid premature death, disability, hospitalisation, revascularisation and surgery, and improve quality of life.[9][3]
• Improve early diagnosis and coordinated management of atherosclerotic disease, acute coronary syndromes, atrial fibrillation, stroke prevention, dyslipidaemia and heart failure.[10][11]
• Expand participation in the Lithuanian Heart and Vascular Disease Prevention Programme and increase its territorial reach, eligible population and clinical focus.[12][10]
• Achieve by 2023 a reduction in standardised cardiovascular mortality among people aged 0–64 from 158.91 to 105 per 100,000 population, and increase prevention-programme participation from 22.3% to 40%.[13]

Implementation

The implementation model combines targeted action in high-inequality territories with national health-system strengthening. It links municipal public health, primary outpatient care, secondary cardiology, specialised tertiary services, emergency medical services, mobile outreach, telemedicine and electronic data exchange to provide integrated, continuous cardiovascular care.[14][15][16]Measures are to be progressively coordinated through 2022, with outcome achievement assessed in 2019 and 2023 and criteria monitored annually.[17]

• Develop nationally recognised, evidence-based prevention information, unified clinical guidelines, service algorithms, protocols and methodologies for risk-factor management, diagnosis, treatment, rehabilitation, referral and patient-flow management. At least 20 instruments are intended for national approval and implementation, with use by at least 90% of relevant public healthcare institutions.[18][19][20]
• Integrate primary healthcare providers and municipal public-health bureaux to promote the health of risk groups, monitor their health status, provide counselling and improve cooperation between public-health and outpatient services.[15][21]
• Deliver risk assessment through family medicine, including personal and family history, lifestyle and cardiovascular-risk assessment, weight, body mass index, waist circumference, blood pressure, laboratory testing and identification of secondary or familial dyslipidaemia.[4]
• Strengthen family medicine by training approximately 400 family doctors, 400 community nurses and 20 public-health specialists, revising professional competencies and enabling more independent prescribing and laboratory-test interpretation where appropriate.[22][23]
• Expand specialised prevention centres and heart-failure services, using multidisciplinary teams for diagnostics, treatment, patient education, outpatient and inpatient follow-up, palliative care and coordination of treatment plans.[3][10]
• Improve regional access through mobile teams, remote cardiology consultations, telemedicine and local or home-based care, particularly in municipalities without permanent outpatient cardiologists or located far from advanced cardiology centres.[24][16]
• Strengthen emergency response by training emergency personnel, improving patient transport, equipping services with appropriate emergency vehicles and applying national emergency and transport algorithms.[25][26]
• Modernise facilities, diagnostic technologies, electronic-health systems and specialised equipment, while assessing prior investments and infrastructure utilisation before further procurement or renewal.[27][11][28]
• Engage the Ministry of Health, National Health Insurance Fund, universities, university and regional hospitals, primary and specialist providers, municipalities, public-health bureaux, professional associations, non-governmental organisations, communities, employers and social partners.[18][24][29]
• Monitor outcomes through mortality, prevention-programme participation, lifestyle-risk factors, service access, consultation volumes, waiting times, referrals, treatment delays, 30-day myocardial-infarction survival, hospitalisation, workforce training and infrastructure indicators.[16][30][19]
• Reduce average cardiology waiting times in targeted territories from 19 days in 2013 to 15 days in 2023, increase average cardiologist visits per resident from 0.14 to 0.17, and reduce tertiary-level consultation referrals from 137 to 116.[13][19]
• Finance implementation with up to 85 million Lithuanian litas, while coordinating health-insurance financing with planned service expansion, avoiding duplication across related cardiovascular programmes and considering earlier European Union and other investments.[28]

Monitoring & Evaluation

Monitoring combines mortality, risk-factor, service-access, treatment-outcome, programme-participation and implementation measures. The framework includes periodic monitoring and evaluation throughout implementation, annual review of criteria, and formal assessment of outcome-indicator achievement in 2019 and 2023; measures may be revised where results indicate this is necessary.[18][17]

• Track cardiovascular mortality nationally and in targeted territories, including standardised mortality among people aged 0–64, mortality from circulatory-system diseases among people aged 45–64, cause-specific mortality, working-age mortality and hospital case fatality. The 2023 target is to reduce standardised cardiovascular mortality among people aged 0–64 from 158.91 to 105 cases per 100,000 population.[3][31][32][33][13]
• Monitor prevention-programme participation, participant characteristics and risk factors. Reported 2009–2012 changes include reductions in arterial hypertension, metabolic syndrome, body mass index and abdominal obesity, alongside persistent dyslipidaemia and increased smoking prevalence.[12]
• Assess lifestyle and population risk factors through municipal-level monitoring, particularly smoking, overweight and physical inactivity, to evaluate public-health bureaux, especially in target areas.[21]
• Measure service access and delivery through outpatient cardiology waiting times, tertiary-referral patterns, cardiologist consultations, mobile and remote consultations, home-based services, public-health service coverage, modernised facilities, trained personnel and use of nationally approved algorithms and protocols.[32][34][33][16][30][19][20]
• Track acute-care outcomes through time from myocardial-infarction symptoms to percutaneous transluminal coronary angioplasty, timely intervention, treatment delays and 30-day survival after myocardial infarction. The target is to reduce average cardiology waiting time in targeted territories from 19 days in 2013 to 15 days in 2023.[19][20]
• Monitor health-promotion implementation and impact periodically, including dissemination of evidence-based information, pilot projects, professional training and activities targeting cardiovascular risk groups.[18][6][22][23]
• Assign specific monitoring responsibilities for municipal risk-factor monitoring to the Ministry of Health or its subordinate institutions, municipal administrations and public-health bureaux. Assign the Ministry of Health responsibility for assessing prior cardiology investments, projects and health-technology use.[21][11]

Several data limitations are recognised. Death registration based on the principal underlying diagnosis does not enable actual mortality among people with heart failure to be assessed reliably, and official repeat-hospitalisation statistics for heart failure were unavailable in the cited evidence. Values for myocardial-infarction treatment-time and 30-day-survival indicators were to be established through a 2015 or separate assessment.[35][36][19]

Although the plan identifies numerous indicators and some implementing bodies, the supplied extracts do not provide a complete reporting timetable, integrated surveillance specification, data-source protocol, evaluation methodology or comprehensive accountability framework.[1][18][16][19]

Costing & Financing

Financing draws on Ministry of Health support, European Union Structural Funds, health-insurance resources and planned investment in infrastructure, workforce, information technology and service expansion. An overall ceiling of up to 85 million Lithuanian litas is planned for measures in this area, while funding for common risk-factor actions is intended to avoid duplication across related cardiovascular programmes.[37][27][34][28]

• Fund the cardiovascular disease risk-group screening and prevention programme through the Lithuanian Ministry of Health, which has supported it since 2006.[37]
• Finance regional cardiovascular infrastructure and service projects through European Union Structural Funds during the 2004–2006 and 2007–2013 programming periods. Reported allocations include 83.4 million Lithuanian litas for an earlier regional project, 156.4 million Lithuanian litas for the Central and Western Lithuania project, and more than 15 million Lithuanian litas for municipal public-health infrastructure.[27][34]
• Consider planned expansion of health-care services when setting financing from the Compulsory Health Insurance Fund budget, while seeking greater service output from the same resources or the same service volume with fewer resources.[28]
• Assess existing infrastructure, equipment utilisation and the results of investments financed during 2004–2006 and 2007–2013 before renewal, procurement or further investment.[38][10][28]
• Provide resources for staff training, prevention centres, health-training facilities, diagnostic equipment, teleconsultation, mobile cardiology teams, emergency vehicles, electronic systems and advanced specialist infrastructure, although no unit costs are provided.[8][38][22][24][25][39]
• Consider incentives for electronic referral and referral evaluation as a means of regulating patient flows, reducing unnecessary referrals and lowering Compulsory Health Insurance Fund expenditure.[40]

Heart failure is identified as an important economic burden because of recurrent hospital admissions and treatment expenditure. European and American countries are reported to allocate up to 3% of total health-care budgets to heart-failure care, but the supplied text gives no equivalent quantified Lithuanian share.[35]

No detailed annual budget, recurrent-cost estimate, national co-financing arrangement, quantified funding gap, resource-mobilisation target or economic assumption is specified beyond the reported allocations, financing sources and efficiency objectives.[27][34][28]